|Publication number||US979993 A|
|Publication date||Dec 27, 1910|
|Publication number||US 979993 A, US 979993A, US-A-979993, US979993 A, US979993A|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (33), Classifications (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
J. F. OBYRNE & T. A. FLOOD.
APPLICATION FILED MAR. 24, 1910.
979,993. Patented Dec. 27, 1910.
WITNESSES INIVENIORJ J06EPH f0. firfi/ve OMHS 1.00 a W v W lu A TTORNE Y8 err srrns remains true JOSEPH FRANCIS OBYRNE, OF CONTACT, NEVADA, AND THOMAS A. FLOOD, 0T SALT LAKE CITY, UTAH.
Specification of Letters latent Patented Dec. 27,1919.
Application filed March 24, 1910. Serial *No; 551,353.
To all whom it may concern.
Be it. known that we, Joanna FRANCIS OBYRNE and THOMAS; A. Fnoon, both citizens of the United States, and residing, respectively, at Contact, in the county of Elko and State of Fevada', and Salt Lake City,
jectiles and consists "in certain novel constru'ctions and combinations of parts as will be hereinafter described and claimed.
In the drawing Figure 1 is a longitudinal section of a rojectile in the form of a cartridge embodying our invention and Fig. 2 is a cross sectional view on about the line 2--2 of Fig. 1. j
This invention is -in the nature of a projectile in the form of a bullet or missile as the case may be, especially designed for use in catching wild animals and .has for an object to provide a projectile carrying a narcotic whoseanesthetic efi'ect will so affect the animal as to render the capture and control of the same easy.
In the construction shown, I provide a projectile with an opening or recess to receive an opiate, or other narcotic or anesthetizing substance and the said recessis shown as opening laterally and it is illustrated in Fig. 2 as annula" in form 'so' an annular body of the substance maybe used and I also illustrate a soluble cover or envelop which may. be of gelatin as more fully described hereinafter.
In the construction shown the projectile is in the form of a bullet B connected with a cartridge D which maybe of the ordinary construction and the bullet B has a point-B, a butt B and an axial shank B connecting the point and butt, the projectile being recessed between the point and butt forming as shown in Fig. 2 an annular recess in which the substance may be'placed and the ends of said recess 0- are undercut at C to aid in retaining the substance when applied as presently described. The substance or chargeA toact as a narcotic may be apornorphine hydrochlorate, or morphine and scopolamin, or the equivalent ofscopolamin, hyoscin', or morphine sulfate, or the hydrochlorate or in fact any of the alkaloids or other substances which will tend to produce sleep or stupor when taken up by thetissues. V
In the case of the larger animals like the elephant and rhinoceros with thick skins, the body of the projectile may be of lead, steel or the -like or other heavy metal while with smaller thin skinned animals some soluble material or such substances as magnesium may be employed as the metalrnag nesium will ordinarily be absorbed byfithe animal tissues in from two to, tour Weeks after entering the same and will leave no trace. This is desirable as it avoids extract the bullet as a. steel bullet 'or steel jacketed bullet will have to be used owing tothe-fact that magnesium will not penetrate due to its low specificgravity. "The cover E s of some soluble substance: preferably gelatin and is in the formofa cylindrical casing fitting between the point and butt of the projectile and coinciding in its external circumference with that oi said point and butt and forms an inclosure: or
envelop retaining the substance A until it has entered the animal.
In operation the animal is .shot in some" fleshy part with a powder charge or other force sufficient to just penetrate the skin or for a short distance into the tissues and melt or dissolve in from ten to fifteen minutes, more or less, and the blood will absorb the substance A and the animal will in from twenty to forty minutes come into the influence of the substance when-it can be easily as Y when in the tissues the gelatin cover will.
captured-and tied up. The drug material A maybe used in the dry form, or if desired in the shape in which it comes for hypodermic injections and when constructed as shown in Figs. 1 and .2 the drug charge is cylindrical or tubular in shape.
The gelatin is employed for strength and to avoid climatic changes in the drug. If
quick action is desired, the gelatin can be is hit by the projectile.
106 knocked off orotherwise removed when the drug will begin to act as soon as the animal calculated for the animals or birds on which" it is designed to use the rojectile and for birds the projectile may e made founder ,and shorter for small rifles.
It is found practice that in to secure a quickaction of the drug charge.
It will be noticed that the cartridge shellextends-at D over the latera opening in the projectile and over the charge and the gelatin cover therefor, when such gelatin cover is employed. .By-extending the cartridge shell over the narcotic charge the dru is protected from the weather by the shell and is also so incased as to prevent mechanical injury or displacement thereof.
a It will be understood that the gelatin cover may or may not be employed, as while it increases the safety and certainty of op eration, it is not really necessary when the drug is protected by the extension ofthe cartridge shell as shown and above described. When the gelatin cover is omitted some suitable binder may be incorporated with or used otherwise with the drug as ordinarily the drug would not be strong enough to stand the shock of leaving the rifle unless held in some way to the projectile.
We claim 1. A projectile having a recess or opening, a narcotic therein and a gelatin like cover for said recess or opening.
2. A projectile having a point, a butt, a connection between the point and the butt and a narcotic between the point and butt and alongside the connection and a gelatinlike cylinder inclosing the narcotic.
3. A. projectile of material adapted to be absorbed by animal tissue and having a point and butt and a central connection bee izvti'een the same and a narcotic between the point and butt and encircling the connection.v i
inclosing the narcotic.
j 3 5. A projectile having a point or butt and a connection between the same of reduced diameter whereby an annular recess is pro- Vided surroundin the connection, the ends of the said recess eingundercut and a narcotic held in said recess. v
6. A projectile of magnesium having a recess or opening and a narcotic therein substantially as described.
7. A projectile of magnesium having a point, a butt spaced therefrom and a relatively smaller connecting portion between the point and butt and a narcotic carried between the point and butt.
8. A projectile of magnesium having a point or'butt, a relatively smaller connecting portion between the same and concentric therewith, a narcotic surrounding said connecting portion between the point and butt and a gelatin cover for the narcotic.
9. A projectile of'magnesium having a laterally openin recess, a narcotic therein and a soluble c osure extending over the said recess.
JOSEPH FRANCISJOBYRNE. THOMAS A. FLOOD.
Witnesses to the signature of Joseph F.
WILLIAM GRANT McCoY, ARTHUR GRAHAM WILLIAMS.
Witnesses to the signature of Thomas A. Flood; I
H. N. MAYO, J. 0. Snow.
rojectile having an annular recess, a narcotic therein and a gelatin like cylinder
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3326129 *||Sep 1, 1965||Jun 20, 1967||Bert B Gould||Miniature disappearing projectile|
|US3837284 *||Sep 7, 1973||Sep 24, 1974||Waldeisen R||Dry charge hypodermic projectile|
|US3948263 *||Aug 14, 1974||Apr 6, 1976||Minnesota Mining And Manufacturing Company||Ballistic animal implant|
|US3982536 *||Nov 15, 1974||Sep 28, 1976||Minnesota Mining And Manufacturing Company||Ballistic inoculation of animals and projectile therefor|
|US6331310||Aug 1, 2000||Dec 18, 2001||Quadrant Holdings Cambridge Limited||Solid dose delivery vehicle and methods of making same|
|US6565871||Aug 31, 2001||May 20, 2003||Elan Drug Delivery Ltd.||Solid dose delivery vehicle and methods of making same|
|US6584910||Apr 19, 2002||Jul 1, 2003||David J. Plass||Animal syringe system|
|US6586006||Jan 5, 2001||Jul 1, 2003||Elan Drug Delivery Limited||Solid delivery systems for controlled release of molecules incorporated therein and methods of making same|
|US6811792||Oct 25, 2002||Nov 2, 2004||Quadrant Drug Delivery Ltd.||Solid dose delivery vehicle and methods of making same|
|US6893657||Feb 27, 2003||May 17, 2005||Quadrant Drug Delivery Ltd.||Solid dose delivery vehicle and methods of making same|
|US7056495||Aug 29, 2003||Jun 6, 2006||Quadrant Drug Delivery Ltd.||Solid dose delivery vehicle and methods of making same|
|US7300919||Sep 18, 2002||Nov 27, 2007||Nektar Therapeutics||Pulmonary delivery of active fragments of parathyroid hormone|
|US7306787||Mar 12, 2002||Dec 11, 2007||Nektar Therapeutics||Engineered particles and methods of use|
|US7521069||Jul 1, 2003||Apr 21, 2009||Novartis Ag||Methods and compositions for pulmonary delivery of insulin|
|US7628978||Aug 19, 2003||Dec 8, 2009||Novartis Pharma Ag||Stabilized preparations for use in metered dose inhalers|
|US7744925||May 20, 2005||Jun 29, 2010||Quadrant Drug Delivery Limited||Solid dose delivery vehicle and methods of making same|
|US7780991||May 20, 2005||Aug 24, 2010||Quadrant Drug Delivery Limited||Solid dose delivery vehicle and methods of making same|
|US7785631||May 20, 2005||Aug 31, 2010||Quadrant Drug Delivery Limited||Solid dose delivery vehicle and methods of making same|
|US7871598||May 10, 2000||Jan 18, 2011||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use|
|US8168223||Jun 21, 2001||May 1, 2012||Novartis Pharma Ag||Engineered particles and methods of use|
|US8246934||Sep 3, 2010||Aug 21, 2012||Novartis Ag||Respiratory dispersion for metered dose inhalers comprising perforated microstructures|
|US8349294||Dec 14, 2010||Jan 8, 2013||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use|
|US8404217||Jul 22, 2005||Mar 26, 2013||Novartis Ag||Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use|
|US8709484||Oct 24, 2008||Apr 29, 2014||Novartis Ag||Phospholipid-based powders for drug delivery|
|US8715623||Oct 31, 2007||May 6, 2014||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US8877162||Dec 6, 2012||Nov 4, 2014||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery|
|US9421166||Apr 8, 2014||Aug 23, 2016||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US9439862||Apr 2, 2014||Sep 13, 2016||Novartis Ag||Phospholipid-based powders for drug delivery|
|US20030140813 *||Jan 29, 2003||Jul 31, 2003||Felix Rosenkranz||Barricade-penetrator|
|US20030159612 *||Feb 28, 2003||Aug 28, 2003||Terrance Ziemack||Ballistic implant system and methods|
|US20040052825 *||Aug 29, 2003||Mar 18, 2004||Roser Bruce J.||Solid dose delivery vehicle and methods of making same|
|USB524121 *||Nov 15, 1974||Feb 3, 1976||Title not available|
|DE2603894A1 *||Feb 2, 1976||Aug 4, 1977||Minnesota Mining & Mfg||Ballistisch implantierbarer formkoerper zur gesteuerten wirkstoffabgabe|